指南与共识呼吸衰竭与机械通气重症综合管理与镇静镇痛

识别国际共识侵袭性曲霉病病例定义中的缺口:不符合这些定义的临床病例综述

Identifying Gaps in the International Consensus Case Definitions for Invasive Aspergillosis: A Review of Clinical Cases Not Meeting These Definitions.
指南 / 共识 · Open Forum Infect Dis · 2024-10-09
一句话结论47例未达共识定义的侵袭性曲霉病患者90天死亡率33%,与221例确诊/临床诊断病例的30%相似,提示现行定义可能遗漏 clinically significant 病例。

本文基于一项回顾性、观察性、多中心调查(澳大拉西亚382例疑似侵袭性曲霉病病例,其中221例确诊/临床诊断病例的发现已发表),分析了47例未达共识定义但被认为有临床意义的病例的临床、微生物学和影像学特征,并与221例确诊/临床诊断病例比较死亡率。47例中15例缺乏经典宿主因素,22例仅有单次曲霉聚合酶链反应阳性,7例胸部CT缺乏典型IA影像学表现,3例支气管肺泡灌洗液半乳甘露聚糖光密度指数处于临界值(<1.0但≥0.5)。中位年龄61岁(IQR 52-68),男性34例(72%),7例(15%)需入住ICU,所有患者原发感染部位均为肺,42例(89%)启动抗真菌治疗。全因90天死亡率为33%,与对照队列(n=221)的30%相似。结论指出当前共识定义存在局限,需进一步研究单次曲霉PCR阳性和无宿主因素的患者。

要点

  • 47例未达共识IA定义的患者90天全因死亡率为33%,与221例确诊/临床诊断IA患者的30%相似。
  • 47例中22例仅有单次曲霉聚合酶链反应阳性,15例缺乏经典宿主因素,7例胸部CT无典型IA表现,3例BALF半乳甘露聚糖光密度指数<1.0但≥0.5。
  • 所有47例患者原发感染部位均为肺,42例(89%)启动了抗真菌治疗,7例(15%)需入住ICU。
  • 中位年龄61岁(IQR 52-68),男性34例(72%)。
  • 作者认为需进一步研究单次曲霉PCR阳性和无宿主因素的患者,以确定未来共识定义是否可能受益于修改。

适用人群与场景

  • 来自澳大拉西亚多中心调查的382例疑似侵袭性曲霉病病例中,47例未达共识定义但被认为有临床意义的病例;所有患者原发感染部位均为肺。

诊断标准与关键阈值

  • 未达国际共识确诊/临床诊断侵袭性曲霉病定义的具体原因:15例缺乏经典宿主因素;22例仅有单次曲霉聚合酶链反应阳性;7例胸部CT缺乏典型IA影像学表现;3例BALF半乳甘露聚糖光密度指数处于临界值(<1.0但≥0.5)。

处置流程与药物剂量

  • 47例中42例(89%)启动了抗真菌治疗;7例(15%)需入住ICU。

研究设计与关键结果

  • 研究类型:基于回顾性、观察性、多中心调查(澳大拉西亚382例疑似IA病例,其中221例确诊/临床诊断病例的发现已发表)的病例分析;样本量47例未达共识定义病例,对照为221例确诊/临床诊断病例。
  • 47例中:15例缺乏经典宿主因素;22例仅有单次曲霉聚合酶链反应阳性;7例胸部CT缺乏典型IA影像学表现;3例BALF半乳甘露聚糖光密度指数<1.0但≥0.5。
  • 中位年龄61岁(IQR 52-68);男性34例(72%);7例(15%)需入住ICU;所有患者原发感染部位均为肺;42例(89%)启动抗真菌治疗。
  • 全因90天死亡率为33%,对照队列(n=221)为30%,两者相似。

证据类型、等级与局限

  • 证据类型:基于回顾性、观察性、多中心调查的病例分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,当前共识定义对IA存在局限;未达定义患者的死亡率与确诊/临床诊断IA患者相似。
  • 作者认为,需进一步研究单次曲霉PCR阳性患者和无宿主因素患者,以确定未来共识定义是否可能受益于修改。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: International consensus definitions for invasive aspergillosis (IA) in research are rigorous, yet clinically significant cases are often excluded from clinical studies for not meeting proven/probable IA case definitions. To better understand reasons for the failure to meet criteria for proven/probable infection, we herein review 47 such cases for their clinical and microbiological characteristics and outcomes.

METHODS: Data on 47 cases that did not meet consensus IA definitions but were deemed significant were derived from a retrospective, observational, multicenter survey of 382 presumed IA cases across Australasia, of which findings of 221 proven/probable infections were recently published. The clinical, microbiological, and radiologic characteristics of these cases were analyzed. Mortality outcomes were compared with those of 221 proven/probable cases.

RESULTS: Of 47 cases studied, 15 lacked classical host factors; 22 exhibited only a single positive Aspergillus polymerase chain reaction result; 7 lacked typical IA radiologic findings on chest computed tomography; and 3 had borderline galactomannan optical density indices (<1.0 but ≥0.5) in bronchoalveolar lavage fluid. The median age of patients was 61 years (IQR, 52-68); 34 were male (72%). Seven patients (15%) required intensive care admission. All patients had lung as the primary site of infection. Antifungal treatment was initiated in 42 patients (89%). All-cause 90-day mortality was 33%, similar to the 30% mortality in the comparative cohort (n = 221).

CONCLUSIONS: Our findings highlight the limitations of current consensus definitions for IA. Notably, the mortality of patients not meeting these definitions was similar to that of patients with proven/probable IA. Further studies, especially of patients with a single positive Aspergillus polymerase chain reaction result and those without host factors, are needed to determine if future consensus definitions may benefit from modifications.

来源:Open Forum Infect Dis,查看原文。版权归原作者所有。

参考来源

  1. Tio SY, Chen SCA, Heath CH, et al. Identifying Gaps in the International Consensus Case Definitions for Invasive Aspergillosis: A Review of Clinical Cases Not Meeting These Definitions. Open Forum Infect Dis. 2024. PMID: 39494451. doi:10.1093/ofid/ofae594

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。